Emergency War Surgery NATO Handbook: Part I: Types of Wounds and Injuries: Chapter
III: Burn Injury
Adjuvant Treatment
United States Department of Defense
The burn patient who has been actively immunized against tetanus should be given a
booster dose of tetanus toxoid. Those patients who have not received prior active
immunization should receive hyperimmune human antitetanus serum as well as an initial dose
of tetanus toxoid, with active immunization continued at weekly intervals until complete.
Unless specifically contraindicated, penicillin is administered to all burn patients
for the first 5 days postburn to prevent beta-hemolytic streptococcal burn wound
infection. Thereafter, antibiotics are administered only on the specific indication of
clinical infection supported by positive bacteriologic cultures.
As previously noted, restlessness and agitation frequently can be relieved by insuring
adequate oxygenation. The need for analgesia is usually minimal except in those patients
with extensive partial-thickness burns. Analgesia, when required in the first 3 days
postburn, should be administered intravenously in appropriately small dosages.
Ileus is a common accompaniment of thermal injury involving 20% or more of the total
body surface, and nasogastric intubation and drainage to prevent emesis and aspiration are
critically important in these patients. It is also important to maintain nasogastric
intubation in all patients who are to undergo air evacuation, not only in the early
postburn period but also later, if evidence of gastrointestinal dysfunction exists.
Approved for public release; Distribution is unlimited.
The listing of any non-Federal product in this CD is not an
endorsement of the product itself, but simply an acknowledgement of the source.
Operational Medicine 2001
Health Care in Military Settings
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
This web version is provided by
The Brookside Associates Medical
Education Division. It contains original contents from the official US
Navy NAVMED P-5139, but has been reformatted for web access and includes
advertising and links that were not present in the original version. This web
version has not been approved by the Department of the Navy or the Department of
Defense. The presence of any advertising on these pages does not constitute an
endorsement of that product or service by either the US Department of Defense or
the Brookside Associates. The Brookside Associates is a private organization,
not affiliated with the United States Department of Defense.
Contact Us · ·
Other Brookside Products
|